INO Inovio Pharmaceuticals Inc

$INO just for some of you who are still questioning Voceryq’s efficacy numbers or for those who’ve been trying very hard to twist the numbers:

$INO LETS HONOR OUR VETERANS TODAY AND EVERYDAY....THEY PUT THEMSELVES ON THE LINE FOR ALL OF US!!!!!!!!

$INO I’ve said this before, but the bashers still don’t seem to understand. Longs are in a winning position here, regardless of the daily price action. We have an FDA approved product and several more products in the pipeline. That’s a fact! If the price goes down its a win, we get an opportunity to accumulate more shares at a discount. When the price goes up, our investments grow in value. Either way, it’s a win win for the longs. The focus now is execution, commercialization, and bringing more innovation to market. Keep your eyes on the bigger picture, stay focused on the long term, and don’t give the bashers your attention. Block out the noise! 🚀

$INO Smart money knows that the recent $80.5M raise completely de-risks the balance sheet. Dilution is in the rearview mirror, and the cash runway is officially locked in through late 2027! 💰✨💲🤑 The next 60 days are going to be absolutely packed with catalyst fuel. Watch for incoming PRs as the initial commercial sale orders for VOCERYQ™ start dropping! Every new order is going to prove the massive market demand for this FDA-approved breakthrough. 📈🔥

$INO Part 2- My bullish thoughts.. Who loaded up on the after-hours dip! 🚀 People panic selling a Q3 EPS miss completely miss the bigger picture. The wider loss was driven by manufacturing scale-up and commercial prep for VOCERYQ—not structural issues. We have a first-ever FDA-approved plasmid DNA immunotherapy launching in 60 days, and the cash runway is fully secured through late 2027. This post-earnings drop is a massive institutional discount. Tomorrow we shake out the weak hands at the open, trap the shorts, and squeeze back over $1.45. Bulls are in control long term. 🐂🔥

$INO Tag The After Hours Ask....INOVIO WILL KEEP ROLLING ALL THE WAY TO $20 Or More In 9 To 12 Months IMHO

$INO A decent close. Looks like a nice U shape pattern happening on the one month chart. Thank you for the Veterans that made our country possible.

$INO no reason to be under $2 after that call. Cash runway for a year assuming no sales. They might never have to dilute again.

$INO Diamond hand here 💪💎 Been through worse but I can see the long term benefits which are not to far in the future 😏 Tomorrow's Scenarios after the Q3 EPS miss ($0.50 vs $0.21 exp). Currently $1.30 (-10%) in AH. 📈📉 🐻 BEAR CASE: Gravity flushes us down to test the recent $1.05 offering price. Panic selling takes over due to high cash burn, breaking through $1.25 support. Drifts lower all day to close near $1.15-$1.20. 🐂 BULL CASE: "Sell the rumor, buy the fact" reversal. Weak hands get shaken out at the open around $1.30, but institutions step in to buy the dip. Market realizes the wider loss was just upfront VOCERYQ launch/manufacturing prep costs. Shorts trap, stock squeezes back to $1.45+. Where are we heading? 🔮

$INO this 👇 Investors are piling in know that the barrier has been broken through. Inovio, passed the hurdle, with its first- FDA APPROVED PRODUCT. Revenues will come in. It’s no longer a “speculative stock.” We transitioned into a “commercial bio pharmaceutical company. “

$INO I listened to and translated the call into Italian, I found it very constructive and targeted. Their drug can be used as a first line, they are preparing for marketing by the first quarter of 2027 in the US and Europe, cash for the whole of 2027. As usual, disproportionate reaction in the aftermarket but we are used to it. We just have to wait and increase with each drop to have a reasonable average price. Imho

$INO For Sure....Mid Dosing Surgery Required To Remove Papillomas For Precigen.....Complete Response Wanes To 43% Going Into 2nd Year Of Treatment....Precigen Is A Viral Vector Based Tech Which Historically Has Re Dosing Issues....Could Re Dosing Be An Issue For Precigen ?????....On The Flipside INOVIO's INO 3107 Requires No Mid Dosing Surgery.....Complete Response For INO 3107 Is 50% In The 2ND Year.....With 54% Complete Response In 3rd Year....In My Opinion INO 3107 Is Far Superior!!!!!!

$INO Our team deployed will cover 90% of RRP Patients 🧬🧬🧬🌏🌍🌎 Random banger for the end. We got the team for sure

$INO In the label, there is no requirement for scoping or surgery!!! That's what we wanted to hear... I listened to $PGEN call and Helen lied!!! And said both labels said this... no Inovio label doesn't because we do not require surgery or scoping... BOOM

$INO Something tells me that tonight, for you afternoon, this earning will be different, constructive. We have the ok from the FDA for ino-3107, enough money for the operations, the lawsuit won with vgxi and more. I am very optimistic. As far as the pps is concerned, these figures are crumbs for me. I aim high, very high and I am waiting. Tori, full speed ahead. Forgive my grammar as always

$INO $MRNA $RVMD Inovio Excellent Call: 1. Partnerships coming Ex USA. 2. UK/EMA filings EOY. 3. Cash on hand $130 Million + Till End of year 2027. 4. FDA Approval validated entire pipeline moving forward. 5. Upward and Onward. ✌️🙏❤️‍🩹

$INO New short data is out, and as anticipated, shorts have dug themselves into an even bigger hole. Short interest is now reported at 22.1 million shares!

$INO been invested 6 years here….i can promise you this ain’t normal. Should be getting nuked based off the past. Which means bottom is in

$INO I don't know how it will close, but today it shows strength, a lot of strength in resisting pressure. Imho

$INO If I had to be in a coma for 12 months and could only put it all on one stock, guess which stock that would be?